Papers
4
Total Citations
52
H-Index
4
About
Piet Ost is a leading urologic oncologist whose research focuses on optimizing treatment strategies for prostate and bladder cancers, with a particular emphasis on surgical staging, quality of life, and shared decision-making. His major contributions include advancing the understanding of pelvic lymph node dissection (PLND) in prostate cancer staging, where he prospectively evaluated complication rates of minimally-invasive extended PLND before curative radiotherapy, demonstrating its feasibility and safety (10 citations). He further assessed the morbidity and oncological outcomes of different PLND approaches, showing how surgical yield influences radiotherapy planning and potential therapeutic effects (9 citations). Ost also pioneered patient-centered research by developing and validating a standardized questionnaire to identify cognitive factors influencing treatment decision-making in localized prostate cancer, empowering men to make well-informed choices between surgery, radiotherapy, and active surveillance (5 citations). His work on health-related quality of life after curative treatments for muscle-invasive bladder cancer provides a comprehensive overview of patient-reported outcomes across different modalities (28 citations). With over 28 citations on his quality-of-life umbrella review alone, Ost’s research has significantly impacted clinical practice by integrating surgical precision, patient perspectives, and evidence-based decision-making in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4